Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.84%
After-hours: Aug 15, 2025, 07:57 PM EDT
Lineage Cell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.36M | -4.14M | -3.27M | -3.03M | -5.76M | -6.54M | -4.78M | -7.16M | -5.2M | -4.4M | -6.36M | -6.12M | -6.78M | -7.09M | -29.19M | -7.84M | -4.8M | -1.45M |
Depreciation & Amortization | 171K | 164K | 151K | 141K | 142K | 175K | 175K | 176K | 170K | 171K | 173K | 193K | 179K | 182K | 191K | 199K | 197K | 286K |
Stock-Based Compensation | 1.24M | 1.22M | 1.31M | 1.33M | 1.27M | 1.16M | 1.06M | 1.27M | 1.28M | 1.03M | 959K | 987K | 1.24M | 1.11M | 918K | 1.14M | 919K | 539K |
Other Working Capital | -2.31M | -587K | -2.88M | 3.57M | -277K | -1.02M | -2.08M | -140K | -2.78M | -2.97M | 65.99M | -1.02M | -4.45M | 27.12M | -409K | 407K | 720K | -76K |
Other Non-Cash Items | 25.77M | -1.86M | -1.52M | -6.26M | 281K | 350K | -698K | -131K | -190K | 99K | -242K | 384K | 2.96M | 589K | -259K | 2M | 100K | 102K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -554K | 941K | 696K | -1.8M | n/a | n/a | n/a | n/a | 1.18M | -1.01M | -2.34M | -5.57M |
Change in Working Capital | -2.35M | -268K | -3.02M | 2.04M | -1.11M | -929K | -1.23M | -134K | -3.02M | -6.34M | -2.83M | -928K | -4.66M | 27.12M | 21.29M | 656K | 502K | -1.33M |
Operating Cash Flow | -5.54M | -4.89M | -6.35M | -5.79M | -5.18M | -5.78M | -6.02M | -5.04M | -6.27M | -11.24M | -8.3M | -5.48M | -7.06M | 21.9M | -5.87M | -4.85M | -5.42M | -7.42M |
Capital Expenditures | -14K | -97K | -365K | 88K | -50K | -38K | -91K | -139K | -256K | -188K | 16K | -286K | -97K | -46K | -146K | -68K | -129K | -11K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.26M | -19.41M | 188K | -40.63M | n/a | n/a | n/a | -10.09M | n/a | 14K | 10.09M |
Purchase of Investments | n/a | n/a | n/a | n/a | -8.76M | n/a | n/a | -3.77M | -4.92M | -7.72M | -12.78M | -40.63M | n/a | n/a | n/a | n/a | n/a | -10.07M |
Sales Maturities Of Investments | n/a | 2M | 3M | 4M | 18K | n/a | 9.83M | 6.03M | 24.33M | 23.33M | 7.67M | n/a | n/a | n/a | -6.02M | n/a | n/a | -6.02M |
Other Investing Acitivies | n/a | n/a | n/a | -200K | n/a | n/a | n/a | 2.26M | 19.41M | -188K | 40.63M | -40.63M | n/a | -46K | 16.11M | n/a | 14K | 6.02M |
Investing Cash Flow | -14K | 1.9M | 2.63M | 3.89M | -8.79M | -38K | 9.74M | 2.12M | 19.16M | 15.43M | -5.1M | -40.91M | -97K | -46K | -146K | -68K | -115K | 10.07M |
Debt Repayment | -14K | -14K | -14K | -13K | -14K | -13K | -13K | -12K | -16K | -13K | -9K | -8K | -7K | -8K | -7K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -23K | -199K | n/a | n/a | -37K | 17K | n/a | -9K | -8K | -13K | -14K | -14K | -13K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -971K | -921K | n/a | n/a |
Other Financial Acitivies | -228K | -15K | -58K | n/a | 86K | 20K | 199K | -17K | -145K | 51K | 131K | 972K | 49K | 381K | 850K | 4.65M | 3.37M | 1.1M |
Financial Cash Flow | -307K | 5.04M | 21.73M | -3K | 105K | 14.02M | -13K | 807K | 5.63M | 1K | 122K | 964K | 33K | 513K | 954K | 3.72M | 11.29M | 20.96M |
Net Cash Flow | -5.57M | 1.99M | 18.05M | -1.86M | -13.95M | 8.13M | 3.99M | -2.45M | 18.43M | 4.08M | -13.36M | -46.06M | -7.25M | 22.33M | -5.05M | -1.19M | 5.8M | 23.53M |
Free Cash Flow | -5.55M | -4.89M | -6.71M | -5.7M | -5.23M | -5.82M | -6.11M | -5.18M | -6.52M | -11.43M | -8.29M | -5.77M | -7.16M | 21.86M | -6.02M | -4.92M | -5.54M | -7.43M |